SCHEMBL312664

SCHEMBL312664

CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(Cl)c21

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.84
KDM4E B2RXH2 5/20 0.84
HSD17B10 Q99714 5/20 0.84
HPGD P15428 4/20 0.84
PMP22 Q01453 1/20 0.83
KCNH2 Q12809 3/20 0.59
POLB P06746 2/20 0.59
OPRM1 P35372 2/20 0.59
PRKD3 O94806 1/20 0.59
ALOX15 P16050 1/20 0.59
CLK2 P49760 1/20 0.59
CLK4 Q9HAZ1 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
CHRM2 P08172 1/20 0.52
CHRM1 P11229 1/20 0.52
OPRD1 P41143 1/20 0.52
LMNA P02545 2/20 0.52
BRD4 O60885 1/20 0.52
TSHR P16473 1/20 0.52
HTT P42858 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10767255 0.99 ALDH1A1 (0.84) ALDH1A1KDM4EHSD17B10HPGDPMP22
Lomefloxacin SCHEMBL29388501 0.92 KDM4E (1.00) ALDH1A1KDM4EHSD17B10HPGDPMP22
Lomefloxacin SCHEMBL29895425 0.92 KDM4E (1.00) ALDH1A1KDM4EHSD17B10HPGDPMP22
Lomefloxacin SCHEMBL34610 0.92 KDM4E (1.00) ALDH1A1KDM4EHSD17B10HPGDPMP22
Lomefloxacin SCHEMBL133835 0.92 KDM4E (1.00) ALDH1A1KDM4EHSD17B10HPGDPMP22
Lomefloxacin SCHEMBL34609 0.92 KDM4E (1.00) ALDH1A1KDM4EHSD17B10HPGDPMP22
Lomefloxacin SCHEMBL9226104 0.92 KDM4E (1.00) ALDH1A1KDM4EHSD17B10HPGDPMP22
Lomefloxacin SCHEMBL8912235 0.91 KDM4E (1.00) ALDH1A1KDM4EHSD17B10HPGDPMP22
Lomefloxacin SCHEMBL30034879 0.91 KDM4E (1.00) ALDH1A1KDM4EHSD17B10HPGDPMP22
Lomefloxacin SCHEMBL42052 0.91 KDM4E (1.00) ALDH1A1KDM4EHSD17B10HPGDPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093381-B2 Method of synthesis of fluoroquinolones BIOCODEX (FR) 2012-01-10 US disclosed
US-20090054643-A1 NOVEL METHOD OF SYNTHESIS OF FLUOROQUINOLONES BIOCODEX (FR) 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054643-A1 NOVEL METHOD OF SYNTHESIS OF FLUOROQUINOLONES NQO2, Q6ZSR9, QARS1 ALDH1A1 3146/4885KDM4E 2435/4885HSD17B10 1768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.